HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Amalric Selected Research

Dyskinesias (Dyskinesia)

3/2013Group III and subtype 4 metabotropic glutamate receptor agonists: discovery and pathophysiological applications in Parkinson's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M Amalric Research Topics

Disease

4Parkinson Disease (Parkinson's Disease)
03/2013 - 12/2002
2Neurodegenerative Diseases (Neurodegenerative Disease)
03/2013 - 01/2006
2Catalepsy
04/2012 - 03/2010
1Dyskinesias (Dyskinesia)
03/2013

Drug/Important Bio-Agent (IBA)

3Glutamic Acid (Glutamate)FDA Link
03/2013 - 03/2010
2Haloperidol (Haldol)FDA LinkGeneric
04/2012 - 03/2010
1Levodopa (L Dopa)FDA LinkGeneric
03/2013
1Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA
03/2013
11-aminocyclopentane-1,3,4-tricarboxylic acidIBA
04/2012
1N,N'-dibenzhydrylethane-1,2-diamine dihydrochlorideIBA
03/2010
1Glutamate Receptors (Glutamate Receptor)IBA
01/2006
1Dopamine (Intropin)FDA LinkGeneric
12/2002